Sonic Healthcare (SHL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
30 Jun, 2026Opening remarks and agenda
The AGM was held on 19 November 2024, opened with acknowledgment of traditional custodians, confirmation of quorum, and hybrid attendance options with detailed participation instructions.
Board members, auditors, and company secretary were introduced, and the minutes of the previous AGM were tabled as read.
Financial performance review
FY24 revenue reached AUD 8,967 million, a 10% increase from FY23, with net profit at AUD 511 million, down 25% due to an 87% drop in COVID-related revenues.
Base business revenue grew 16%, with 6% organic growth and contributions from acquisitions.
EBITDA (excluding US West division sale gain) was AUD 1,602 million, down 6% year-on-year.
Revenue split: USA 24%, Australia 22%, Germany 20%, Switzerland 10%, UK 7%.
Strong balance sheet maintained, with gearing below pre-pandemic averages despite significant investments.
Board and executive committee updates
Professor Suzanne Crowe joined the Remuneration and Nomination Committee; Professor Christine Bennett joined the Risk Management Committee.
Mr. Lou Panaccio retired after 19 years of service; Ms. Nicola Wakefield Evans to join as independent non-executive director in February 2025.
Board diversity objective met, with 44% female directors.
Latest events from Sonic Healthcare
- Revenue up 10% to A$8.97B, strong organic growth and acquisitions drive future gains.SHL
H2 20242 Jun 2026 - FY2026 guidance targets up to 19% EPS growth, driven by acquisitions and margin expansion.SHL
H2 20252 Jun 2026 - Net profit up 17% and margin expansion, with acquisitions and contracts fueling future growth.SHL
H1 20252 Jun 2026 - Revenue up 17% and EBITDA up 10%, with guidance and dividend growth maintained.SHL
H1 20262 Jun 2026 - Leadership transition, strong FY 2025 growth, and all resolutions passed at the AGM.SHL
AGM 202520 Nov 2025